with that in mind...Don't be surprised if BP is looking at Brilacidin/UC very carefully for the PR'd Clinical Trials being planned and discussed with FDA...both Domestic and Foreign BP's...but this time IMO it won't be a UP type deal...if UC is as successful as it indicated in the Phase I mini-trial.